Snap closed at $4.73, down 1.46% on Wednesday after earlier gains tied to a new health-focused advertising push. Investors are focused on whether healthcare and pharmaceutical ad budgets can become a durable revenue stream for the company, creating uncertainty around the sustainability of the rally.
Snap closed at $4.73, down 1.46% on Wednesday after earlier gains tied to a new health-focused advertising push. Investors are focused on whether healthcare and pharmaceutical ad budgets can become a durable revenue stream for the company, creating uncertainty around the sustainability of the rally.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
